Clinical experience with gemcitabine in pancreatic carcinoma.

Abstract

The treatment of advanced pancreatic carcinoma has been viewed with pessimism. Because of the lack of activity of commonly used agents, there is no consensus regarding a standard chemotherapy regimen. Assessment of response is neither uniform nor reproducible. Debilitating tumor-related symptoms, including pain, anorexia, weight loss, and impaired… (More)

Topics

  • Presentations referencing similar topics